Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005)

A study to asses the safety and efficacy of MK0429 in postmenopausal women with osteoporosis.

Completed

Looking for future studies?

Key information

Conditions

Post-Menopausal Osteoporosis Bone Diseases Bone Diseases, Metabolic Metabolic Diseases Musculoskeletal Diseases Nutritional and Metabolic Diseases Osteoporosis Osteoporosis, Postmenopausal

Age range

50 year–75 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 2

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Person is a women with osteoporosis who is unwilling or unable to take other treatments for osteoporosis

Exclusion criteria

Person has had a previous fracture
Person has rheumatoid arthritis. Person has has certain types of cancer
Person has donated blood or has been in another investigational study within the last 4 weeks

Treatment and study plan

MK0429

Drug

Sponsors and collaborators

Lead sponsor

Merck Sharp & Dohme LLC

Industry

Registry information

Important dates

Study start: 2000
Primary completion: 2002
Study completion: 2002
First posted: Sep 21, 2007
Registry last updated: Jul 29, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed